Laurente, Ladylee .
HRN: 24-46-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2024
CEFUROXIME 1.5GM (VIAL)
01/29/2024
01/30/2024
IV
1.5gm
3 Doses Q8
Sp CS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes